...
首页> 外文期刊>Urology >Role of ATP-sensitive K+ channels in relaxation of penile resistance arteries.
【24h】

Role of ATP-sensitive K+ channels in relaxation of penile resistance arteries.

机译:ATP敏感性K +通道在抗阴茎动脉松弛中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To investigate the functional presence of adenosine triphosphate (ATP)-sensitive potassium (K+) channels (K(ATP)) in penile resistance arteries by evaluating the relaxant effects of the selective K(ATP) channel openers, cromakalim and levcromakalim, and also the involvement of K(ATP) channels in the relaxation of two drugs currently used in the treatment of erectile dysfunction (ie, prostaglandin E1 [PGE1] and sildenafil). METHODS: Penile resistance arteries were dissected from the horse corpus cavernosum and mounted in microvascular myographs for isometric tension recording. The arteries were precontracted with phenylephrine, and the responses to several vasodilators were tested in the absence and presence of K+ channel blockers. RESULTS: Cromakalim and levcromakalim evoked complete concentration-dependent relaxations that were blocked by 3 microm of the selective K(ATP) channel inhibitor glibenclamide. Raising extracellular K+ (25 mM) inhibited the relaxations to PGE1 and to the selective inhibitor of the cyclic adenosine monophosphate-specific phosphodiesterase (PDE4) rolipram. At a concentration selective for calcium-activated K+(K(Ca)) channels (3 mM), tetraethylammonium inhibited rolipram responses but not those of PGE1. However, glibenclamide significantly reduced the relaxation to both PGE1 and rolipram, but not those induced by the selective inhibitor of the type 5 cyclic guanosine monophosphate-specific phosphodiesterase (PDE5). CONCLUSIONS: The present results suggest a functional role for K(ATP) channels in the relaxation of penile resistance arteries, as well as their differential involvement in the vasodilation to drugs used in the treatment of organic erectile dysfunction. They mediated relaxation to PGE1 and cyclic adenosine monophosphate-elevating agents, but not those of cyclic guanosine monophosphate-elevating agents such as sildenafil.
机译:目的:通过评估选择性K(ATP)通道开放剂cromakalim和levcromakalim和K(ATP)通道也参与了目前用于治疗勃起功能障碍的两种药物(即前列腺素E1 [PGE1]和西地那非)的舒张作用。方法:从海绵体解剖出阴茎阻力动脉,并将其安装在微血管肌电图仪中以记录等距张力。动脉已与去氧肾上腺素预收缩,并且在不存在和存在K +通道阻滞剂的情况下测试了对几种血管扩张剂的反应。结果:Cromakalim和levcromakalim引起完全浓度依赖性的舒张,被3微米的选择性K(ATP)通道抑制剂格列本脲阻断。升高细胞外K +(25 mM)抑制PGE1和环状单磷酸腺苷特异性磷酸二酯酶(PDE4)咯利普兰的选择性抑制剂的松弛。在对钙激活的K +(K(Ca))通道具有选择性的浓度(3 mM)下,四乙铵抑制了咯利普兰反应,但对PGE1没有抑制作用。但是,格列本脲显着降低了对PGE1和咯利普兰的松弛,但并未降低由5型环鸟苷单磷酸特异性磷酸二酯酶(PDE5)的选择性抑制剂诱导的松弛。结论:目前的结果表明K(ATP)通道在阴茎阻力动脉舒张中发挥功能作用,以及它们在血管扩张中对有机勃起功能障碍治疗药物的不同作用。他们介导松弛到PGE1和环磷酸单磷酸腺苷升高剂,而不是环鸟嘌呤单磷酸环己酯升高剂如西地那非。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号